Abstract
Sudden death, myocardial infarction and heart failure contribute significantly to cardiovascular mortality in the general population and are a common manifestation of coronary artery disease [1]. Acute coronary syndrome (ACS) and sudden death may represent the first manifestation of CAD in about 50% of patients. Furthermore, while the hospital mortality of patients with ACS has greatly improved in the past 20 years, out of hospital deaths are not declining. The main problem is therefore our poor ability to recognize those patients before the appearance of the manifestation of CAD. In fact, while it is relatively easy to identify and treat a patient with symptomatic CAD this is not true for the other individuals. It is therefore of paramount importance to identify those patients at risk of developing an acute manifestation of CAD prior to any clinical event. Although a significant coronary stenosis can often develop prior to ACS, it is clear now that about 50% of the acute events are caused by the complication of nonstenotic coronary segments [2, 3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123:e18–e209
Fuster V, Stein B, Ambrose JA et al (1990) Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82:II47–II59
Stone GW, Maehara A, Lansky AJ et al (2011) PROSPECT Investigators A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226–235
Stone GW, Maehara A, Lansky AJ (2002) Third Report of the National Cholesterol Education Program (NCEP) export Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106:3143–3421
Lloyd-Jones DM (2010) Cardiovascular Risk Prediction Basic Concepts, Current Status, and Future Directions. Circulation 121:1768–1777
Conroy RM, Pyorala K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003
Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study. Circulation 105:310–315
Lloyd-Jones DM, Larson MG, Beiser A, Levy D (1999) Lifetime risk of developing coronary heart disease. Lancet 353:89–92
Eagle KA, Ginsburg GS, Musunuru K et al (2010) Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation 121:1447–1454
Rose G (1992) The Strategy of Preventive Medicine. New York, NY: Oxford University Press
Pasternak RC, Abrams J, Greenland P et al (2003) 34th Bethesda Conference: Task force #1-Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 41:1863–1874
Getz L, Sigurdsson JA, Hetlevik I et al (2005) Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ 331:551
U.S. Preventive Services Task Force (2009) Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 151:474–482
Pearson TA, Mensah GA, Alexander RW et al (2003) Centers for Disease Control and Prevention. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511
National Heart Lung and Blood Institute, National Cholesterol Education Project (2002) Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: National Institutes of Health
Helfand M, Buckley DI, Freeman M et al (2009) Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force. Ann Intern Med 151:496–507
D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, for the CHD Risk Prediction Group (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation 286:180–187
Akosah K, Schaper A, Cogbil C, Schoenfeld P (2003) Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 41:1475–1479
Brindle P, Emberson J, Lampe F et al (2003) Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327:1267
Naghavi N, Falk E, Hecht HS for the SHAPE et al (2006) Task Force.From Vulnerable Plaque to Vulnerable Patient-Part III:Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report. Am J Cardiol 98:2–15
Greenland P, Alpert JS, Beller GA et al; American College of Cardiology Foundation; American Heart Association(2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 56:50–103
Falk E (2006) Pathogenesis of Atherosclerosis. J Am Coll Cardiol 47:7–12
Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108:1664–1672
Velzen JE, Schuijf JD, de Graaf FR et al (2011) Diagnostic performance of non-invasive multidetector computed tomography coronaryangiography to detect coronary artery diseaseusing different endpoints: detection of significantstenosis vs. detection of atherosclerosis European Heart Journal 32:637–645
Boden WE, O’Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516
Min JK, Dunning A, Lin FY et al; CONFIRM Investigatore (2011) Age-and Sex-Related Differences in All-Cause Mortality Risk Based on Coronary Computed Tomography Angiography Findings Results From the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 Patients Without Known Coronary Artery Disease. J Am Coll Cardiol 58:849–860
Ferencik M (2010) Assessment of coronary claque burden by computed tomography: getting closer step by step. Heart 96: 75–576
Motoyama S, Sarai M, Harigaya H et al (2009) Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 54:49–57
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Casolo, G. (2012). Screening and High CV Risk Patients. In: Cademartiri, F., Casolo, G., Midiri, M. (eds) Clinical Applications of Cardiac CT. Springer, Milano. https://doi.org/10.1007/978-88-470-2522-6_29
Download citation
DOI: https://doi.org/10.1007/978-88-470-2522-6_29
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2521-9
Online ISBN: 978-88-470-2522-6
eBook Packages: MedicineMedicine (R0)